NPI registry status
Active
2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1215931670 M.D.
Verify on CMS → Peter Wong, M.D.
Ophthalmic Plastic and Reconstructive Surgery Physician in Rockville Centre, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 303 in Ophthalmic Plastic and Reconstructive Surgery Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 725 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 642
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.0K
41 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Peter Wong, M.D. filed 1,974 Medicare Part D claims in 2024 as an Ophthalmic Plastic and Reconstructive Surgery Physician in Rockville Centre, New York, prescribing 92% generic.
- 2K
- Part D claims, 2024
- 92%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥83rd
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Peter Wong, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1215931670), first enumerated 06/13/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,974 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.0K in reported industry payments (41 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Peter Wong, M.D.'s individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1215931670 · Ophthalmic Plastic and Reconstructive Surgery Physician
NPI-10 · ENUM-LEGACY · TAX-TRACE · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1215931670
- ENUM-LEGACY 2005
- TAX-TRACE 303
- RX-MID 1,974
- BOOK-THIN 21 in New York
- PHOTO-ENUM Sherif Khalil, MD · 2005
Peter Wong, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,974 ≥ 83rd percentile 83% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Peter Wong, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Peter Wong, M.D.?
Quality data not reportedPrimary specialty
Ophthalmic Plastic and Reconstructive Surgery Physician
Medicare Part D claims
1,974 207% vs specialty avg
Specialty distribution in New York
How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among New York providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Ophthalmic Plastic and Reconstructive Surgery Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1215931670 |
|---|---|
| Specialty | Ophthalmic Plastic and Reconstructive Surgery Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/13/2005 |
Hospital and facility affiliations
Facilities where Peter Wong, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Ophthalmic Consultants OF Long Island
Rockville Centre, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Peter Wong, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.0K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Peter Wong, M.D.. To verify Peter Wong, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Peter Wong, M.D. - brand share 8.0%
Ophthalmic Plastic and Reconstructive Surgery Physician average
8% brand-name claims vs 92% generic, on 1,974 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,974
Total Claims
$186K
Total Drug Cost
725
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,047.667
- Total Day Supply
- 24,635
- Brand vs Generic
- 8% brand / 92% generic
- Brand Drug Cost
- $163K
- Generic Drug Cost
- $23K
- Opioid Claims
- 413 (20.9% rate)
- Antibiotic Claims
- 200
Patient Demographics
- Average Patient Age
- 74.5 years
- Avg HCC Risk Score
- 1.19
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 41, 65-74: 336, 75-84: 254, 85+: 94
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Peter Wong, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Erythromycin
Erythromycin
736 claims
- Tramadol Hcl
Tramadol Hcl
337 claims
- Tobramycin-Dexamet… 197
Tobramycin-Dexamethasone
197 claims
- Tobramycin 128
Tobramycin
128 claims
- Doxycycline Hyclate 126
Doxycycline Hyclate
126 claims
- Acetaminophen-Code… 68
Acetaminophen-Codeine
68 claims
- Methylprednisolone 65
Methylprednisolone
65 claims
- Azasite 58
Azasite
58 claims
| Drug | Claims |
|---|---|
| Erythromycin Erythromycin Base | 736 |
| Tramadol Hcl | 337 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 197 |
| Tobramycin | 128 |
| Doxycycline Hyclate | 126 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 68 |
| Methylprednisolone | 65 |
| Azasite Azithromycin | 58 |
| Cephalexin | 55 |
| Ofloxacin | 27 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Ophthalmic Plastic and Reconstructive Surgery Physician in NY →
All providers in New York →
Compare specialties →
Ophthalmic Plastic and Reconstructive Surgery Physician Overview
How Peter Wong, M.D. fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.
303
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
44
States with Ophthalmic Plastic and Reconstructive Surgery Physician
642
Avg Claims per Provider
Peter Wong, M.D.'s 1,974 claims are above the specialty average of 642.
Nationwide Ophthalmic Plastic and Reconstructive Surgery Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Wong, both outside New York so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Wong.
One of 21 Ophthalmic Plastic and Reconstructive Surgery Physician providers enrolled in New York, 5 are shown here.
Frequently Asked Questions
What is Peter Wong, M.D.'s specialty? ▼
Peter Wong, M.D. specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in Rockville Centre, New York. Credentials: M.D..
How much does Peter Wong, M.D. prescribe under Medicare Part D? ▼
In 2024, Peter Wong, M.D. wrote 1,974 Medicare Part D claims totaling $186K in drug costs for 725 beneficiaries.
Where is Peter Wong, M.D. located? ▼
Peter Wong, M.D. is located at 2000 N VILLAGE AVE, Rockville Centre, NY, 11570. Phone: (516) 766-2519.
What is Peter Wong, M.D.'s NPI number? ▼
Peter Wong, M.D.'s National Provider Identifier (NPI) is 1215931670, issued on 06/13/2005.
Does Peter Wong, M.D. prescribe more brand-name or generic drugs? ▼
Peter Wong, M.D.'s prescribing is 8% brand-name and 92% generic drugs by claim count, with $163K in brand drug costs.
Does Peter Wong, M.D. prescribe opioids? ▼
Yes, Peter Wong, M.D. had 413 opioid claims in 2024 with an opioid prescribing rate of 20.9%.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US? ▼
There are 303 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 44 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 642 Medicare Part D claims per year.
What drugs does Peter Wong, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Peter Wong, M.D.'s most frequently prescribed drugs include Erythromycin, Tramadol Hcl, Tobramycin-Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Peter Wong, M.D. accept Medicare? ▼
Peter Wong, M.D. appears in CMS Medicare data with 1,974 Part D claims and 725 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Peter Wong, M.D.'s credentials? ▼
Peter Wong, M.D.'s NPI is 1215931670 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.